WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO) reported purchases during August 2015 of the company’s common stock by its Chief Executive Officer, Dr. Shai N. Gozani and Chief Financial Officer, Thomas T. Higgins. Details of these transactions may be found on the U.S. Securities and Exchange Commission’s EDGAR website at the following links: Form 4 SNG 08 11 15 Form 4 TTH 08 20 15 Form 4 TTH 08 28 15 About NeuroMetrix NeuroMetrix is an innovative health-care company that deve


| < Prev | Next > |
|---|
